Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 3, 2017
Finance
Clever chemistry
...million) seed round followed in 2015 from Merck Ventures, Aglaia Oncology Fund, Novo Seeds and
EVA Basel
...
Read More
BioCentury
|
Dec 21, 2015
Financial News
Inthera Bioscience completes venture financing
...Venture financing Raised: EUR3.4 million ($3.7 million) Investors: MS Ventures; Aglaia Oncology Fund; Novo Seeds;
EVA Basel
WIR...
Read More
BioCentury
|
Jul 27, 2015
Financial News
Memo Therapeutics completes venture financing
...2015-07-22 Type: Venture financing Raised: CHF2.3 million ($2.4 million) Investors: Redalpine Venture Partners; Zuercher Kantonalbank;
EVA Basel
WIR...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Jun 3, 2017
Finance
Clever chemistry
...million) seed round followed in 2015 from Merck Ventures, Aglaia Oncology Fund, Novo Seeds and
EVA Basel
...
Read More
BioCentury
|
Dec 21, 2015
Financial News
Inthera Bioscience completes venture financing
...Venture financing Raised: EUR3.4 million ($3.7 million) Investors: MS Ventures; Aglaia Oncology Fund; Novo Seeds;
EVA Basel
WIR...
Read More
BioCentury
|
Jul 27, 2015
Financial News
Memo Therapeutics completes venture financing
...2015-07-22 Type: Venture financing Raised: CHF2.3 million ($2.4 million) Investors: Redalpine Venture Partners; Zuercher Kantonalbank;
EVA Basel
WIR...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page
